Remove Access Remove Cannabis Remove Cultivation Remove Microdosing
article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving. What is microdosing? A microdose is a dose that does not elicit a perceivable intoxicating or trip-like effect. This is the mechanism for healing depression and learning new ways of thinking.

History 119
article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Tony Lovasco’s psychedelics bill aims to provide therapeutic access to psilocybin for people with severe mental health conditions in the coming days.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Research Shows Strong Support for Natural Therapeutics

Veriheal

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Cannabis and magic mushrooms for the win! Pioneering Psychedelic Research.

Therapy 98
article thumbnail

Prohibition Partners (UK) Report: Rising Tides: North American Drug Regulations and the Impact on Big Psychedelic Business – Part 2

Cannabis Law Report

With narrow channels for psychedelic access in North America’s current regulatory frameworks, what opportunities do current regulations create and how are companies currently creating revenue streams in these restrictive environments? Part 2: Opportunities or Threats? . We are still seeing a sector emerge,’ Altshuler told PSYCH.

article thumbnail

Press Release: Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression

Cannabis Law Report

Optimi Health is developing a robust IP portfolio through its Health Canada Dealer’s License and utilizing its 20,000 sq ft state-of-the-art production and research facilities to cultivate, test, and synthesize high-quality mushroom strains and psychedelic substances such as MDMA.

article thumbnail

St Vincent & Grenadines Allowing Med Plant Science Ltd to produce psychedelic compounds

Cannabis Law Report

The team at Microdose, the world’s biggest medical psychedelic conference , said the country’s move to permit Med Plant Science Ltd to produce psychedelic compounds makes it the first country to legalize all psychedelic medicine. . Just last month the country sent its first shipment of 110 kilos of medical cannabis to Germany.

article thumbnail

What seniors need to know before getting a medical marijuana card

The Cannigma

The percentage of Americans over 65 who had reported using cannabis in the past year had increased tenfold between 2006 to 2018, from 0.4% But as mainstream as cannabis has become, there are still some things any senior should consider before deciding whether to get a medical marijuana card. Access to healthcare professionals.